Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro Behavior and tumor amelioration potential.

MLA

Padhi, Santwana, et al. “Revisiting the Nanoformulation Design Approach for Effective Delivery of Topotecan in Its Stable Form: An Appraisal of Its in Vitro Behavior and Tumor Amelioration Potential.” Drug Delivery, vol. 23, no. 8, Oct. 2016, pp. 2827–37. EBSCOhost, https://doi.org/10.3109/10717544.2015.1105323.

APA

Padhi, S., Mirza, M. A., Verma, D., Khuroo, T., Panda, A. K., Talegaonkar, S., Khar, R. K., & Iqbal, Z. (2016). Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro Behavior and tumor amelioration potential. Drug Delivery, 23(8), 2827–2837. https://doi.org/10.3109/10717544.2015.1105323

Chicago

Padhi, Santwana, Mohd. Aamir Mirza, Devina Verma, Tahir Khuroo, Amulya K. Panda, Sushama Talegaonkar, Roop Krishen Khar, and Zeenat Iqbal. 2016. “Revisiting the Nanoformulation Design Approach for Effective Delivery of Topotecan in Its Stable Form: An Appraisal of Its in Vitro Behavior and Tumor Amelioration Potential.” Drug Delivery 23 (8): 2827–37. doi:10.3109/10717544.2015.1105323.